Drug similar to Ozempic slowed Parkinson’s disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and…
2024-05-19 03:47:23
The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and…
People sitting by a pier during sunset in Singapore. Roslan Rahman | Afp | Getty Images Singapore’s economic losses due to heat stress could nearly double to $1.64 billion in…
Artist Refik Anadol uses generative AI to produce images, seen here as part of the “Echoes of the Earth: Living Archive” exhibition at Serpentine North, London. Hugo Glendinning | Courtesy…
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger…
Daniel Grill | Tetra Images | Getty Images Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage…
Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against…
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The blockbuster diabetes drug Ozempic could be manufactured…
Alexey Krukovsky | Istock | Getty Images Viking Therapeutics shares closed more than 15% higher on Tuesday after the company said its experimental weight loss pill showed positive results in…
The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for…
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries…